24
Mar

While biotech IPOs continued strong last week as shares of Versartis climbed 49% on its opening day, analysts and investors were left chewing on a nasty drop in the Nasdaq Biotechnology Index on Friday.

…read more

Source: Is the great biotech stock rally kaput?

    

0 No comments